Tag Archive for: ExeVir

Exevir BIO executive team at EIB. © EIB/Exevir BIO
financing

ExeVir receives EIB risk finance for multiple COVID-19 nanobody

With the help of a €25m loan from the European Investment Bank, ExeVir BIO BV will advance clinical trials with its COVID-19 nanobody XVR012.

Read more